The Norwegian COVID-19 Data Portal aims to bundle the Norwegian research efforts and offers guidelines, tools, databases and services to support Norwegian COVID-19 researchers. The Portal is a collaboration between the European Bioinformatics Institute (EMBL-EBI), ELIXIR Europe and ELIXIR Norway.

If you are working with COVID-19 data in Norway and have questions about the ELIXIR Norway short- and long-term research support, please contact Helpdesk. The Helpdesk is happy to answer any questions related to COVID-19 data management and data sharing.


Support services

The ELIXIR Norway Helpdesk is a nationally support centre which supports COVID-19 research. A general overview can be found at the Helpdesk pages.

If you need help please contact the Helpdesk here.

ELIXIR Norway provide a number of services to Norwegian COVID-19  researcher and life science researchers in general. More information can be found here.

Here you can find information on how to deposit COVID-19 related data to public repositories.

Here you will information how you can get access to viral and host datasets. 

Here you can search the latest Coronavirus articles and preprints from EuropePMC.

Here you can find guidelines and recommendations for Open data and FAIR sharing.

Why sharing COVID-19 data: Learn how ELIXIR Norway in collaboration with EMBL and the COVID-19 Data Portal supports research, services and data sharing. Video: Jeff Dowling/EMBL

SARS-CoV-2 Database: This is a curated sequence database for the SARS-COV-2 virus hosted at the University of Tromsø. The SARS-CoV-2 database focuses on decluttering and standardising contextual data. To learn more, please see the database page.

The European Life-Sciences Infrastructure for Biological Information (ELIXIR) provides support for COVID-19 research in Europe.  Their support overview lists helpful information like how to store or find data, what tools and workflows are established for analysing data, and recommendations for keeping data FAIR (Findable, Accessible, Interoperable and Reusable). A list of COVID-19 publications by the ELIXIR community can be found here.  

ELIXIR Norway is one of 22 national nodes in the European collaboration effort. It consist of five subnational nodes: UiB (Bergen), UiT (Tromsø), NTNU (Trondheim), NMBU (Ås), and UiO (Oslo). See the COVID-19 resource page for more information on how ELIXIR Norway contributes to research related to the pandemic.

The ELIXIR-CONVERGE project is supported by the European Commission to substantiate data standardisation and management within the life sciences. It constitutes four objectives and is split into eight Work Packages. Three of these, WP7, WP8 and WP9, are dedicated to the European COVID-19 response.

Official Norwegian COVID-19 information

The Norwegian Institute of Public Health (NIPH) governs the latest SARS-COV-2 related information concerning the COVID-19 disease in Norway.

Statistics on testing, reported cases and hospitalisation are provided at a national level and for individual regions and municipalities.

General guidelines and travel regulations have been introduced to reduce the spread of the COVID-19 disease in Norway. Advices are continuously adjusted according to the given situation in Norway and abroad.

The vaccination process in Norway is monitored by the Norwegian Immunisation Registry (SYSVAK). The vaccination statistics and approved vaccines are further provided by NIPH.

The Research Council of Norway is the state’s main funder of research projects in Norway. EU funded projects in Norway are also listed in their project bank.


General and European COVID-19 information

The WHO monitor the global SARS-COV-2 outbreak and provide a panel of researchers to manage the variant nomenclature and classification system currently in use. In collaboration with the ECDC the WHO additionally monitors viruses involved in the seasonal influenza.

The European Centre for Disease Prevention and Control (ECDC) is advocating the protection of EU citizens from infectious diseases. It provide various resources concerning the European Union and the wider European Economic Area (EU/EEA).